Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Most patients on isotretinoin for acne experience mild, dose-related side effects, but the connection to depression or bowel disease is uncertain.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

Topical finasteride may better target hair follicles without significant benefits over oral form.

Hair cortisol is a reliable way to measure long-term stress in animals.

Combining amino acid and stem cell therapy may help manage hepatocutaneous syndrome in dogs.

Glucocorticoid treatment improved symptoms in a girl with Satoyoshi disease.

The combination treatment showed a higher response rate but no significant survival benefits.

Topical minoxidil can cause severe liver failure.

High glucocorticoids cause pancreatic malfunction and malabsorption, reversible with enzyme supplements.

PRP shows promise in treating joint and spine issues, but translating lab results to humans is challenging.

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

Vaccination is crucial for public health, but anti-vaccine movements are a concern.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

Orlistat might block the body's ability to absorb thyroid medication.

A man's bald spot grew hair after starting cancer treatment with gefitinib.

Oral retinoids can cause side effects ranging from mild to severe, including birth defects, and require careful monitoring and contraception.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Hair growth is influenced by factors like genetics and nutrition, and more research is needed to understand hair loss and growth mechanisms.

Hair loss in Cronkhite-Canada syndrome may be caused by autoimmune factors, not just stress or malabsorption.

Open-label placebos can reduce stress and improve exam performance.

Stopping afatinib improved a rare scalp condition in a patient.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

Melatonin may help with nerve pain, a hepatitis C drug is effective but has side effects, a treatment for mouth sores works but can cause blood issues, ear reconstruction with an implant is safe, HIV transmission from mother to child in Taiwan is now 0% with treatment, certain blood problems are more common in people with a tongue condition, a gene and being overweight are linked to hair loss in some women, a new technique could reduce radiation for lung nodule patients, a hepatitis treatment may lower cancer recurrence after a procedure, and adding extra screening improves tuberculosis detection in patients with lung infections.

A new mutation in the K6b gene caused a girl's late-appearing nail condition.

Stopping infliximab and using strong topical steroids can regrow hair lost due to psoriasiform alopecia.

Methotrexate for rheumatoid arthritis often causes side effects like diarrhea, fatigue, and hair loss, especially at higher doses.